HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Featured Stories

UK Rejects Blood Glucose Health Claim For White Mulberry Supplement

J&J Limited On Offering Consumer Business Separation Details, Clear On Q4 Revenue Drag

Sales & Earnings Consumer M & A

US Modernized Cosmetics Law’s ‘Weak’ Safety Substantiation Standard Leaves NGOs Wanting

Spotlight On Cosmetics Law

Compliance Clock Starts Ticking Under Historic Modernization of Cosmetic Regulations Act

Companies have one year to comply with US FDA registration and product listing requirements under the Modernization of Cosmetic Regulations Act of 2022, part of the $1.7tr omnibus spending package signed by President Joe Biden on 29 December. Trade groups applauded the historic milestone and the legislation’s departure from previous proposals, including the elimination of user fees.

Regulation FDA

Latest Articles

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

Health Explore this Topic

Set Alert for Health

Latest From Health

Hemp Supplement Sales Continue In US Without FDA Acknowledgement As Lawful Products

Decision, explained by Principal Deputy Commissioner Woodcock, turns page on FDA’s 2019 announcement, after hemp was de-scheduled in 2018 farm bill, it would consider rulemaking for lawful use of hemp in supplements.

Cannabidiol CBD FDA

OTC Shortages Top Of Mind For North American, European and Asia Pacific Consumers

An overwhelming majority of consumers surveyed by IT consultancy Capgemini are concerned they will not be able to obtain the OTC health products they require or want. In the event of shortages – which are currently affecting consumers across Europe – many respondents said they would substitute with another brand, or in some cases not purchase at all.

International Health

US Consumer Health Industry In 2023: FDA Decision On Lawful Use Of Hemp Top Of Mind

“Right now, it looks like [FDA’s] hands are tied because that's their message … But they're holding both ends of the rope. Come on, get that knot undone,” says AHPA president Michael McGuffin. “To anybody who's looking at this as an outsider, you would say, ‘What is the agency doing?’’ says NPA CEO Daniel Fabricant.

Dietary Supplements Cannabidiol CBD

Outlook 2023: Health, Beauty, Wellness Company Leaders Offer Views On Year Ahead

This year, top companies in the consumer health, wellness and beauty sectors are focused on meeting consumers’ changing self-care needs (at price points they can afford), integrating digital technologies, and driving sustainable innovations and business practices that are good for people and planet. Leaders from J&J, Haleon, Bayer, Coty and Beiersdorf weigh in.

Business Strategies Advertising, Marketing & Sales

OTC Codeine Cough Syrups Meet UK Conditions For Rx Reverse Switch, Says Expert Body

Could codiene linctus cough syrups be reverse-switched from OTC to Rx status in the UK? A panel of independent medicines experts suggests they should be, based on UK drugs law and their use in illegal cocktail Purple Drank.

United Kingdom Health

Alliance Pharma Has High Hopes For Recovering Chinese Market in 2023

Alliance Pharma is hopeful the end to COVID-19 movement restrictions in China will help to boost demand for its key consumer health brands Kelo-cote and Nizoral in 2023.

Europe China
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

Washington State Continues Taking Cues From California; Toxic-Free Cosmetics Act Is Back

Washington State’s Toxic-Free Cosmetics Act would ban use of any and all PFAS, matching work California started in 2020 and finished with legislation enacted last year. It also would blacklist ortho-phthalates, formaldehyde, methylene glycol and any other chemical determined by the department to release formaldehyde, among other deemed hazardous substances.

Legislation Cosmetic Ingredients

Hemp Supplement Sales Continue In US Without FDA Acknowledgement As Lawful Products

Decision, explained by Principal Deputy Commissioner Woodcock, turns page on FDA’s 2019 announcement, after hemp was de-scheduled in 2018 farm bill, it would consider rulemaking for lawful use of hemp in supplements.

Cannabidiol CBD FDA

Outlook 2023: Health, Beauty, Wellness Company Leaders Offer Views On Year Ahead

This year, top companies in the consumer health, wellness and beauty sectors are focused on meeting consumers’ changing self-care needs (at price points they can afford), integrating digital technologies, and driving sustainable innovations and business practices that are good for people and planet. Leaders from J&J, Haleon, Bayer, Coty and Beiersdorf weigh in.

Business Strategies Advertising, Marketing & Sales

P&G To Test ‘Benign Elasticity’ Seen In Q2 With More Pricing Planned

“A world in which all of the market growth is driven by pricing is obviously not sustainable,” CFO Andre Schulten acknowledged in P&G’s fiscal 2023 second-quarter earnings presentation. The firm remains focused on investing in its brands and driving household penetration while weathering economic headwinds and taking additional pricing in February.

Sales & Earnings Commercial

EU Member States Propose Broad PFAS Restriction Under REACH

Per- and polyfluoroalkyl substances (PFAS) number in the thousands, and all are being targeted with a REACH restriction proposal submitted to the European Chemicals Agency by the national authorities of Denmark, Germany, the Netherlands, Norway and Sweden.

Regulation Cosmetic Ingredients

HBW Market Executive Decisions: Sabinsa, Nutrition21, Council Of Manufacturing Association

Sabinsa founder edits selenium research book; Everwell adds Nutrition21 executives; and ACI’s Hockstad leads NAM Council of Manufacturing Associations.

Consumer Dietary Supplements
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

Hemp Supplement Sales Continue In US Without FDA Acknowledgement As Lawful Products

Decision, explained by Principal Deputy Commissioner Woodcock, turns page on FDA’s 2019 announcement, after hemp was de-scheduled in 2018 farm bill, it would consider rulemaking for lawful use of hemp in supplements.

Cannabidiol CBD FDA

Improving US FDA Food Programs Starts At Top, Former Senior Agency Officials Say

Former acting commissioner Stephen Ostroff and Sharon Lindan Mayl, previously a senior advisor to FDA commissioner on food programs, say Reagan-Udall report was accurate in finding that establishing food program leadership with defined authorities is key to improving the programs, which include regulation of supplement manufacturing and marketing.

Consumer FDA

US Consumer Health Industry In 2023: FDA Decision On Lawful Use Of Hemp Top Of Mind

“Right now, it looks like [FDA’s] hands are tied because that's their message … But they're holding both ends of the rope. Come on, get that knot undone,” says AHPA president Michael McGuffin. “To anybody who's looking at this as an outsider, you would say, ‘What is the agency doing?’’ says NPA CEO Daniel Fabricant.

Dietary Supplements Cannabidiol CBD

Outlook 2023: Health, Beauty, Wellness Company Leaders Offer Views On Year Ahead

This year, top companies in the consumer health, wellness and beauty sectors are focused on meeting consumers’ changing self-care needs (at price points they can afford), integrating digital technologies, and driving sustainable innovations and business practices that are good for people and planet. Leaders from J&J, Haleon, Bayer, Coty and Beiersdorf weigh in.

Business Strategies Advertising, Marketing & Sales

Alliance Pharma Has High Hopes For Recovering Chinese Market in 2023

Alliance Pharma is hopeful the end to COVID-19 movement restrictions in China will help to boost demand for its key consumer health brands Kelo-cote and Nizoral in 2023.

Europe China

Boiron's Sales Grow Double-Digits In 2022 Despite Difficult End To Year

French homeopathy specialist Boiron enjoyed a good 2022 after a few challenging years as a result of COVID-19 and France's decision to exclude homeopathic medicines from health insurance coverage.

Europe Health
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

OTC Shortages Top Of Mind For North American, European and Asia Pacific Consumers

An overwhelming majority of consumers surveyed by IT consultancy Capgemini are concerned they will not be able to obtain the OTC health products they require or want. In the event of shortages – which are currently affecting consumers across Europe – many respondents said they would substitute with another brand, or in some cases not purchase at all.

International Health

Outlook 2023: Health, Beauty, Wellness Company Leaders Offer Views On Year Ahead

This year, top companies in the consumer health, wellness and beauty sectors are focused on meeting consumers’ changing self-care needs (at price points they can afford), integrating digital technologies, and driving sustainable innovations and business practices that are good for people and planet. Leaders from J&J, Haleon, Bayer, Coty and Beiersdorf weigh in.

Business Strategies Advertising, Marketing & Sales

PAGB Calls Out ‘Partial And Incomplete’ Reports Of UK OTC Cough & Cold Shortages

There are no OTC analgesic supply issues in UK despite higher than normal demand, says consumer heathcare industry association PAGB in response to what it labels partial and incomplete reporting” in the country's media. HBW Insight looks at NielsenIQ market data for the week ending 7 Janurary to get behind the headlines. 

United Kingdom Health
See All
UsernamePublicRestriction

Register